Sponsor Pipeline

HighField Biopharmaceuticals Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07678684 A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive… Glioma Recruiting
Phase 1
NCT05861895 HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors Solid Tumors, Adult Recruiting
NCT07601334 Safety and Activity of HF50 in Patients With Advanced Solid Tumors Advanced Solid Tumors Not Yet Recruiting
Early Phase 1
NCT06822998 HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors Advanced Solid Tumors Recruiting
Disease Areas
Glioma (1)
Get alerts when HighField Biopharmaceuticals Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free